Hui Xu

机构：First Affiliated Hospital of Zhengzhou University · ORCID：0009-0007-9551-0634

发表论文 21 篇 · 总被引 223 次 · h-index 9

代表论文

• Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology (2023 · World Journal of Gastroenterology · 被引 31)
• The ceRNA network regulates epithelial-mesenchymal transition in colorectal cancer (2023 · Heliyon · 被引 28)
• THBS2-producing matrix CAFs promote colorectal cancer progression and link to poor prognosis via the CD47-MAPK axis (2025 · Cell Reports · 被引 26)
• Macrophage-derived exosomes in cancer: a double-edged sword with therapeutic potential (2025 · Journal of Nanobiotechnology · 被引 24)
• The relationship between miRNA-210 and SCN1B in fetal rats with hypoxic-ischemic brain injury (2022 · Bioscience Reports · 被引 23)
• Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges (2024 · Cancer Medicine · 被引 18)